A 38 per cent increase in revenues helped PDI cut its operating loss to $1.7m (€1.3m) in the first quarter, furthering the contract sales provider’s goal of achieving profitability by the end of the year.
PDI has entered into a strategic alliance with The Medical Affairs Company (TMAC) to offer “a more complete set of field-based commercialisation solutions”.
PDI posted a larger operating loss in Q1 2009 than in the previous year, with the company blaming the decline on the expiration, termination and postponement of contracts.
Troubled contract sales and marketing firm PDI has recently won a
much-needed new sales contract and made two new top executive
appointments as part of ongoing efforts to turn its flagging
business around.
AstraZeneca has pulled the plug on a long-running service contract
with PDI, adding another blow to the company who last week reported
a dive from profit to loss in 2005, with a net loss of nearly $20m
(€16m), versus net income of...
Emerging biopharmaceutical company, Align Pharmaceuticals, has
enlisted sales and marketing services provider, PDI, to provide a
40-person sales force for its three newly acquired oncology
products.
PDI, who provides sales and marketing services to the
pharmaceutical industry, have received a new sales representative
contract in the US from GlaxoSmithKline (GSK), worth $65-70m
(€55-59m).